Gastrointestinal Lipase Inhibitor
Semantic Scholar uses AI to extract papers important to this topic.
Antiobesity treatment is recommended for selected patients in whom lifestyle modification is unsuccessful. Two antiobesity drugs… Expand Orlistat is an oral inhibitor of gastrointestinal lipase used for weight reduction in obese patients. Although most adverse drug… Expand OBJECTIVE
The purpose of this study was to assess the effect of orlistat, a gastrointestinal lipase inhibitor, on body weight… Expand OBJECTIVE: To assess the efficacy and tolerability of orlistat (Xenical®) in producing and maintaining weight loss over a 12… Expand BACKGROUND
Orlistat is a gastrointestinal lipase inhibitor that reduces dietary fat absorption by approximately 30%, promotes… Expand OBJECTIVE
To evaluate the long-term efficacy and tolerability within primary care settings of orlistat, a gastrointestinal lipase… Expand CONTEXT
Orlistat, a gastrointestinal lipase inhibitor that reduces dietary fat absorption by approximately 30%, may promote… Expand BACKGROUND
Long-term maintenance of weight loss remains a therapeutic challenge in obesity treatment.
This… Expand BACKGROUND
We undertook a randomised controlled trial to assess the efficacy and tolerance of orlistat, a gastrointestinal lipase… Expand Excessive intake of dietary fat contributes to the development and maintenance of both obesity and hyperlipidemia. Inhibition of… Expand